Seasonal Flu

Recent Context
A surge in seasonal influenza cases across Delhi-NCR has underscored the urgency of vaccination, particularly for vulnerable groups such as the elderly and immunocompromised individuals.

Understanding Seasonal Influenza

• Definition: A contagious respiratory illness caused by influenza viruses.
• Global Burden: According to global health bodies, annual cases exceed 1 billion, with 3–5 million severe cases and 290,000–650,000 fatalities. Over 99% of pediatric deaths linked to flu occur in developing nations.
• Transmission: Spreads through respiratory droplets when infected individuals cough or sneeze.
• Symptoms: Common signs include sudden onset of fever, persistent cough, sore throat, muscle pain, and exhaustion. Symptoms typically emerge 1–4 days post-infection and last ~7 days.
• Severity: Ranges from mild to life-threatening, especially with delayed medical intervention.
• Treatment: Most recover without medication, but antivirals (e.g., oseltamivir) are critical for severe cases. Over-the-counter drugs like paracetamol help manage symptoms.
• Prevention: Annual vaccination is the most effective shield. Options include injectable (inactivated/recombinant) and nasal spray (live attenuated) vaccines.

Flu vs. Common Cold

• Similarities: Both cause cough, sore throat, and nasal congestion.
• Differences:
  • Viruses: Flu (Influenza A/B) vs. Cold (Rhinovirus).
  • Severity: Flu often leads to severe complications; colds are milder.

Influenza Virus Types

1. Type A: Subtypes like H1N1 and H3N2 circulate seasonally; responsible for pandemics.
2. Type B: Divided into Yamagata/Victoria lineages; causes regional outbreaks.
3. Type C: Rare, mild infections.
4. Type D: Primarily affects livestock; no human infections reported.

• Seasonal Peaks in India: January–March and post-monsoon (August–October), dominated by Influenza A/B.

India’s Mitigation Strategies

• Surveillance: Real-time monitoring of Influenza-Like Illness (ILI) and Severe Acute Respiratory Infections (SARI) via IDSP and VRDL networks.
• Public Awareness: Campaigns to educate on prevention, symptoms, and timely care.
• Healthcare Protocols: Guidelines for ventilatory support, treatment, and triage to reduce mortality.
• Antiviral Access: Free distribution of oseltamivir (Tamiflu) under regulated sales (Schedule H1).
• Healthcare Worker Safety: Provision of N-95 masks and PPE kits.

Challenges

• Virus Mutation: High population density, poor hygiene, and antibiotic misuse accelerate viral evolution.
• Low Vaccination Coverage: Excluded from national immunization programs; limited awareness and affordability.
• Healthcare Disparities: Rural/marginalized groups face barriers in accessing vaccines/treatments.
• Data Gaps: Underreporting in private healthcare hampers surveillance.
• Climate Impact: Alters transmission patterns and seasonal peaks.

Way Forward

1. Boost Preparedness: Prioritize high-risk groups (children, elderly, chronic patients).
2. Vaccination Strategy: Integrate flu shots into public health programs; subsidize costs.
3. Targeted Campaigns: Address myths and emphasize vaccine efficacy.
4. Strengthen Surveillance: Include private hospitals in data networks.
5. Policy Reform: Mandate flu vaccines for vulnerable populations under state policies.